Eesti Akadeemiline Farmaatsia Selts

Active Registry code 80232463 MTÜ Tartu linn Registered 3 Mar 2006
Compare

Eesti Akadeemiline Farmaatsia Selts is a MTÜ based in Tartu linn, registry code 80232463, status: active. Main activity: Research and experimental development on natural sciences and engineering. Its annual report for 2025 shows revenue of €0 and 1 employees.

Turnover
—
State taxes
601 €
↓ 32.6% vs Q1 2026
Labour taxes
628 €
↓ 35.7% vs Q1 2026
Employees
—

Q2 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2025 0 €
    industry median 0 € · companies in the industry: 1 073

Taxes and turnover

Q1 2024 – Q2 2026
Labour taxes per employee, € Q1 2025: 1 207 € · +21.0% vs Q4 2024 · industry median 1 781 € · above 35% of the industry
01 0002 0003 0004 000Q1 2024 Company: 294 € Industry median: 2 040 €Q1·24Q2 2024 Company: 3 135 € Industry median: 2 008 €Q2·24Q3 2024 Company: 0 € Industry median: 1 961 €Q3·24Q4 2024 Company: 998 € Industry median: 1 673 €Q4·24Q1 2025 Company: 1 207 € Industry median: 1 781 €Q1·25Q2 2025 Company: — Industry median: 1 781 €Q2·25Q1 2026 Company: — Industry median: 2 039 €Q1·26Q2 2026 Company: — Industry median: 1 893 €Q2·2601 0002 0003 0004 000Q1 2024 Company: 294 € Industry median: 2 040 €Q2 2024 Company: 3 135 € Industry median: 2 008 €Q2·24Q3 2024 Company: 0 € Industry median: 1 961 €Q4 2024 Company: 998 € Industry median: 1 673 €Q4·24Q1 2025 Company: 1 207 € Industry median: 1 781 €Q2 2025 Company: — Industry median: 1 781 €Q2·25Q1 2026 Company: — Industry median: 2 039 €Q2 2026 Company: — Industry median: 1 893 €Q2·26
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Employees Q1 2025: 3 · −25.0% vs Q4 2024
012345Q1 2024 Company: 5Q1·24Q2 2024 Company: 2Q2·24Q3 2024 Company: 2Q3·24Q4 2024 Company: 4Q4·24Q1 2025 Company: 3Q1·25Q2 2025 Company: —Q2·25Q1 2026 Company: —Q1·26Q2 2026 Company: —Q2·26012345Q1 2024 Company: 5Q2 2024 Company: 2Q2·24Q3 2024 Company: 2Q4 2024 Company: 4Q4·24Q1 2025 Company: 3Q2 2025 Company: —Q2·25Q1 2026 Company: —Q2 2026 Company: —Q2·26
State taxes, € Q2 2026: 601 € · −32.6% vs Q1 2026
02 0004 0006 000Q1 2024 Company: 1 419 €Q1·24Q2 2024 Company: 5 983 €Q2·24Q3 2024 Company: 0 €Q3·24Q4 2024 Company: 3 707 €Q4·24Q1 2025 Company: 3 438 €Q1·25Q2 2025 Company: 3 819 €Q2·25Q1 2026 Company: 892 €Q1·26Q2 2026 Company: 601 €Q2·2602 0004 0006 000Q1 2024 Company: 1 419 €Q2 2024 Company: 5 983 €Q2·24Q3 2024 Company: 0 €Q4 2024 Company: 3 707 €Q4·24Q1 2025 Company: 3 438 €Q2 2025 Company: 3 819 €Q2·25Q1 2026 Company: 892 €Q2 2026 Company: 601 €Q2·26
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q2 2026 — 601 628 —
Q1 2026 — 892 976 —
Q2 2025 — 3 819 4 197 —
Q1 2025 — 3 438 3 621 3
Q4 2024 — 3 707 3 990 4
Q3 2024 — — — 2
Q2 2024 — 5 983 6 269 2
Q1 2024 — 1 419 1 469 5

Financials by year

2016 – 2025
Revenue, € 2025: 0 € · industry median 0 € · above 5% of the industry
0501001502016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 0 € Industry median: 0 €20192020 Company: 0 € Industry median: 150 €20202021 Company: 0 € Industry median: 0 €20212022 Company: 0 € Industry median: 103 €20222023 Company: 0 € Industry median: 76 €20232024 Company: 0 € Industry median: 0 €20242025 Company: 0 € Industry median: 0 €20250501001502018 Company: — Industry median: —2019 Company: 0 € Industry median: 0 €20192020 Company: 0 € Industry median: 150 €2021 Company: 0 € Industry median: 0 €20212022 Company: 0 € Industry median: 103 €2023 Company: 0 € Industry median: 76 €20232024 Company: 0 € Industry median: 0 €2025 Company: 0 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 31 166 € · +267.4% vs 2024 · industry median 0 € · above 90% of the industry
-20 000-10 000010 00020 00030 00040 0002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: -1 647 € Industry median: 3 €20192020 Company: 3 376 € Industry median: 28 €20202021 Company: 5 486 € Industry median: 1 €20212022 Company: 11 746 € Industry median: 0 €20222023 Company: -1 819 € Industry median: 0 €20232024 Company: -18 613 € Industry median: 0 €20242025 Company: 31 166 € Industry median: 0 €2025-20 000-10 000010 00020 00030 00040 0002018 Company: — Industry median: —2019 Company: -1 647 € Industry median: 3 €20192020 Company: 3 376 € Industry median: 28 €2021 Company: 5 486 € Industry median: 1 €20212022 Company: 11 746 € Industry median: 0 €2023 Company: -1 819 € Industry median: 0 €20232024 Company: -18 613 € Industry median: 0 €2025 Company: 31 166 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € thousand 2025: 108 051 € · −10.0% vs 2024
02550751001252016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 76 315 €20192020 Company: 79 691 €20202021 Company: 85 177 €20212022 Company: 96 923 €20222023 Company: 95 104 €20232024 Company: 120 101 €20242025 Company: 108 051 €202502550751001252018 Company: —2019 Company: 76 315 €20192020 Company: 79 691 €2021 Company: 85 177 €20212022 Company: 96 923 €2023 Company: 95 104 €20232024 Company: 120 101 €2025 Company: 108 051 €2025
Equity, € thousand 2025: 107 657 € · +40.7% vs 2024
02550751001252016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 76 315 €20192020 Company: 79 691 €20202021 Company: 85 177 €20212022 Company: 96 923 €20222023 Company: 95 104 €20232024 Company: 76 491 €20242025 Company: 107 657 €202502550751001252018 Company: —2019 Company: 76 315 €20192020 Company: 79 691 €2021 Company: 85 177 €20212022 Company: 96 923 €2023 Company: 95 104 €20232024 Company: 76 491 €2025 Company: 107 657 €2025
Employees 2025: 1 · −50.0% vs 2024 · industry median 1 · above 5% of the industry
0.00.51.01.52.02016 Company: 0 Industry median: —20162017 Company: 0 Industry median: —20172018 Company: 0 Industry median: 120182019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 120202021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 120232024 Company: 2 Industry median: 120242025 Company: 1 Industry median: 120250.00.51.01.52.02018 Company: 0 Industry median: 12019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 12021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 22023 Company: 0 Industry median: 120232024 Company: 2 Industry median: 12025 Company: 1 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 0 31 166 14 479 108 051 107 657 1
2024 0 -18 613 28 152 120 101 76 491 2
2023 0 -1 819 0 95 104 95 104 0
2022 0 11 746 0 96 923 96 923 0
2021 0 5 486 0 85 177 85 177 0
2020 0 3 376 0 79 691 79 691 0
2019 0 -1 647 0 76 315 76 315 0
2018 — — — — — 0
2017 — — — — — 0
2016 — — — — — 0
2015 — — — — — 0
2014 — — — — — 0
2013 — — — — — 0
2012 — — — — — 0
2011 — — — — — 0
2010 — — — — — 0
2009 — — — — — 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
28.2 %
Net profit / revenue
Return on equity (ROE)
28.9 %
Net profit / equity
Return on assets (ROA)
28.8 %
Net profit / assets
Equity ratio
99.6 %
Equity / assets
Debt ratio
0.4 %
Liabilities / assets
Current ratio
274.24
Current assets / current liabilities
Revenue per employee
110 702 €
Revenue / average full-time employees
Labour cost per employee per month
1 207 €
Labour costs / employees / 12 months (incl. employer taxes)

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 28 Jul 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 25 Jun 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 26 Jun 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 7 May 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 4 Jul 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 30 Jun 2021 Company’s own e-Äriregister
2019 1 Jan 2019 – 31 Dec 2019 30 Jun 2020 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the non-profit association in all transactions.

Owners

No owner information.

Beneficial owners

  • Andres Lust
    Management board member(s) · since 28 Jul 2026
  • Daisy Volmer
    Management board member(s) · since 28 Jul 2026
  • Liis Preem
    Management board member(s) · since 6 Oct 2025

Founders and other persons

No other persons.

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 72101Research and experimental development on natural sciences and engineering Main
  • 9499Activities of other membership organisations n.e.c.
Rulings
Number, date Title Deadline State Document
M 20034858 / 19
16 Mar 2026
Amendment entry In force
16 Mar 2026
PDF
M 20034858 / 18
30 Oct 2025
Amendment entry In force
30 Oct 2025
PDF
M 20034858 / M5
21 Oct 2025
Ruling to eliminate deficiencies 5 Nov 2025 Deficiencies eliminated
30 Oct 2025
PDF
M 20034858 / 17
12 Mar 2024
Amendment entry In force
12 Mar 2024
PDF
M 20034858 / 16
7 May 2023
Amendment entry In force
7 May 2023
PDF
M 20034858 / 15
1 Feb 2023
Amendment entry In force
1 Feb 2023
PDF
M 20034858 / 14
28 Feb 2022
Amendment entry In force
28 Feb 2022
PDF
M 20034858 / 13
30 Apr 2020
Amendment entry In force
30 Apr 2020
PDF
M 20034858 / 12
4 Mar 2019
Amendment entry In force
4 Mar 2019
PDF
M 20034858 / 11
2 Apr 2018
Amendment entry In force
2 Apr 2018
PDF
M 20034858 / M4
20 Mar 2018
Ruling to eliminate deficiencies 30 Mar 2018 Deficiencies eliminated
28 Mar 2018
PDF
M 20034858 / 10
22 Dec 2017
Amendment entry In force
22 Dec 2017
PDF
M 20034858 / 9
4 Dec 2017
Amendment entry In force
4 Dec 2017
PDF
M 20034858 / 8
18 Sep 2017
Amendment entry In force
18 Sep 2017
PDF
M 20034858 / M3
14 Sep 2017
Ruling to eliminate deficiencies 21 Sep 2017 Deficiencies eliminated
18 Sep 2017
PDF
M 20034858 / 7
13 Jun 2016
Amendment entry In force
13 Jun 2016
PDF
M 20034858 / 6
26 Jun 2014
Amendment entry In force
26 Jun 2014
PDF
M 20034858 / M2
6 Jun 2014
Ruling to eliminate deficiencies 6 Jul 2014 Deficiencies eliminated
25 Jun 2014
PDF
M 20034858 / 5
7 Feb 2014
Amendment entry In force
7 Feb 2014
PDF
M 20034858 / M1
4 Feb 2014
Ruling to eliminate deficiencies 6 Mar 2014 Deficiencies eliminated
5 Feb 2014
PDF
M 34858 / 4
25 Feb 2008
Amendment entry In force
25 Feb 2008
PDF
M 34858 / 3
19 Jun 2007
Amendment entry In force
19 Jun 2007
PDF
M 34858 / 2
19 Feb 2007
Amendment entry In force
19 Feb 2007
PDF
M 34858
3 Mar 2006
First entry In force
3 Mar 2006
PDF

Sources: e-Äriregister and EMTA. Data updated 2 Nov 2026. Open at the source ↗ · Report an error in the data